Data derived from PhenomiR
| PubMed ID | disease | disease class | tissue | expression | foldchange max | foldchange min | genes | study design | method |
| 18577219 |
Glioblastoma multiforme, somatic - 137800 |
Cancer |
brain |
miRNA downregulation |
- |
8.0 |
- |
Patient study phenotype-control |
quantitative PCR
|
| 16854228 |
Colorectal cancer - 114500 |
Cancer |
colorectum |
miRNA downregulation |
- |
- |
- |
Patient study phenotype-control |
quantitative PCR
|
| 16854228 |
Colorectal cancer - 114500 |
Cancer |
HCT-15 cell |
miRNA downregulation |
- |
- |
- |
Cell culture study |
quantitative PCR
|
| 18607389 |
Colorectal cancer - 114500 |
Cancer |
colorectum |
miRNA downregulation |
- |
1.1 |
- |
Patient study phenotype-control |
quantitative PCR
|
| 18270258 |
Thyroid carcinoma, follicular - 188470 (Thyroid carcinoma, conventional follicular adenoma - 0) |
Cancer |
thyroid gland |
miRNA overexpression |
- |
8.1 |
- |
Patient study phenotype-control |
quantitative PCR
|
| 17363563 |
Glioblastoma multiforme, somatic - 137800 |
Cancer |
U-251 cell |
miRNA downregulation |
- |
17.0 |
- |
Cell culture study |
quantitative PCR
|
| 18442408 |
Ovarian cancer - 604370 (Epithelial ovarian cancer - 0) |
Cancer |
ovary cancer cell |
miRNA overexpression |
- |
2.6 |
- |
Patient study phenotype-phenotype |
quantitative PCR
|
| 18478077 |
Leukemia, acute myeloid - 601626 |
Cancer |
blood |
miRNA overexpression |
- |
- |
- |
Patient study phenotype-control |
quantitative PCR
|
| 18973228 |
Medulloblastoma - 155255 |
Cancer |
cerebellum |
miRNA downregulation |
- |
14.2857 |
- |
Patient study phenotype-control |
quantitative PCR
|
| 18537969 |
Non-Hodgkin lymphoma, somatic - 605027 |
Cancer |
lymph node |
miRNA downregulation |
- |
- |
- |
Patient study phenotype-control |
quantitative PCR
|
| 16192569 |
Breast cancer - 114480 |
Cancer |
T-47D cell |
miRNA overexpression |
- |
5.19 |
- |
Cell culture study |
quantitative PCR
|
| 16192569 |
Breast cancer - 114480 |
Cancer |
SK-BR-3 cell |
miRNA overexpression |
- |
12.42 |
- |
Cell culture study |
quantitative PCR
|
| 18223217 |
Hepatocellular carcinoma - 114550 (Hepatocellular carcinoma, associated with hepatitis B/C viral infection and cirrhosis - 0) |
Cancer |
liver |
miRNA overexpression |
- |
2.5 |
- |
Patient study phenotype-phenotype |
quantitative PCR
|
| 18728182 |
Immunological - 0 (Monoclonal gammopathy of undetermined significance (MGUS) - 0) |
Immunological |
plasma cell |
miRNA downregulation |
- |
6.66667 |
- |
Patient study phenotype-control |
miRNA microarray
|
| 18728182 |
Multiple myeloma - 254500 |
Cancer |
plasma cell |
miRNA downregulation |
- |
2.38095 |
- |
Patient study phenotype-control |
miRNA microarray
|
| 16754881 |
Ovarian cancer - 604370 |
Cancer |
ovary |
miRNA downregulation |
- |
- |
- |
Patient study phenotype-control |
array CGH
|
| 16754881 |
Breast cancer - 114480 |
Cancer |
breast epithelium |
miRNA overexpression |
- |
- |
- |
Patient study phenotype-control |
array CGH
|
| 16754881 |
Melanoma and neural system tumor syndrome - 155755 |
Cancer |
cell culture |
miRNA downregulation |
- |
- |
- |
Cell culture study |
array CGH
|
| 16192569 |
Breast cancer - 114480 |
Cancer |
MCF-7 cell |
miRNA overexpression |
- |
6.66 |
- |
Cell culture study |
quantitative PCR
|
| 16192569 |
Breast cancer - 114480 |
Cancer |
MDA-MB-231 cell |
miRNA overexpression |
- |
6.69 |
- |
Cell culture study |
quantitative PCR
|
| 16192569 |
Breast cancer - 114480 |
Cancer |
MDA-MB-361 cell |
miRNA overexpression |
- |
22.47 |
- |
Cell culture study |
quantitative PCR
|
| 16192569 |
Prostate cancer - 176807 |
Cancer |
PC-3 cell |
miRNA overexpression |
- |
2.9 |
- |
Cell culture study |
quantitative PCR
|
| 16192569 |
Prostate cancer - 176807 |
Cancer |
PPC-1 cell |
miRNA overexpression |
- |
1.99 |
- |
Cell culture study |
quantitative PCR
|
| 16192569 |
Prostate cancer - 176807 |
Cancer |
DU-145 cell |
miRNA overexpression |
- |
4.39 |
- |
Cell culture study |
quantitative PCR
|
| 16192569 |
Prostate cancer - 176807 |
Cancer |
Tsu-Pr1 cell |
miRNA overexpression |
- |
1.49 |
- |
Cell culture study |
quantitative PCR
|
| 16192569 |
Prostate cancer - 176807 |
Cancer |
LNCaP cell |
miRNA overexpression |
- |
7.42 |
- |
Cell culture study |
quantitative PCR
|
| 16192569 |
Squamous cell carcinoma, head and neck - 601400 |
Cancer |
squamous cell carcinoma cell line |
miRNA overexpression |
- |
7.46 |
- |
Cell culture study |
quantitative PCR
|
| 16192569 |
Squamous cell carcinoma, head and neck - 601400 |
Cancer |
squamous cell carcinoma cell line |
miRNA overexpression |
- |
4.53 |
- |
Cell culture study |
quantitative PCR
|
| 18766170 |
Lung cancer - 211980 |
Cancer |
serum |
miRNA overexpression |
- |
- |
- |
Patient study phenotype-control |
deep sequencing
|
| 16192569 |
Pancreatic cancer - 260350 |
Cancer |
PANC-1 cell |
miRNA overexpression |
- |
12.74 |
- |
Cell culture study |
quantitative PCR
|
| 16192569 |
Lung cancer - 211980 |
Cancer |
lung cancer cell line |
miRNA overexpression |
- |
4.96 |
- |
Cell culture study |
quantitative PCR
|
| 16192569 |
Hematological - 0 |
Hematological |
K-562 cell |
miRNA overexpression |
- |
18.28 |
- |
Cell culture study |
quantitative PCR
|
| 18607389 |
- |
- |
embryo |
miRNA overexpression |
- |
2.08 |
- |
Bioprocess study |
quantitative PCR
|
| 16192569 |
Lung cancer - 211980 |
Cancer |
A-549 cell |
miRNA overexpression |
- |
7.93 |
- |
Cell culture study |
quantitative PCR
|
